Purpose and Overview

In medicine, translational research emerged as an attempt to relate basic findings with the advances in the clinical practice during the 1990s. Since then, it has been a priority among researchers and academics as well as the organizations that fund research to expand the treatment's scope to include patients of all backgrounds and ages. In his presentation, Dr. Jochen Reiser shares shifting paradigms and unprecedented possibilities in medicine that all researchers and clinicians can use to make the most of their careers in this era of translational medicine. As a renowned nephrologist, he will talk about his career, research, and path to science advocacy through the institutions he worked. He will summarize his renal research, that lead to the discovery of suPAR (soluble urokinase plasminogen activator receptor) as a global, circulating risk factor for chronic kidney disease (CKD) as well as for acute kidney injury (AKI).